Democratizing access to AI

November 18, 2021
Luca Finelli | Novartis

Luca Finelli, Head of the Insights Strategy & Design team at Novartis, explains how in collaboration with Microsoft, we hope to democratize AI drug development and empower researchers and medical doctors to solve healthcare challenges more efficiently.

©2021 Novartis AG

Research Area
- Medical, health and genomics
Project
- Science Engine

Watch Next

Lessons from deploying HealthBots with experts-in-the-loop
March 3, 2026
Anson Ho,

Mohit Jain
Microsoft Research India 2025 Highlights
December 31, 2025
Inside Microsoft Research Asia: Fundamental research powering the future of AI
December 16, 2025
Peng Cheng,

Baining Guo,

Changho Hwang

, et. al.
Accelerating MRI image reconstruction with Tyger
December 9, 2025
Karen Easterbrook,

Ilyana Rosenberg
Sub-Population Identification of Multi-morbidity in Sub-Saharan African Populations
August 13, 2025
Skyler Speakman
Scalable emulation of protein equilibrium ensembles with BioEmu
July 10, 2025
Frank Noé
Transforming Tumor Boards: AI Agents and the New Era of Personalized Cancer Care
May 5, 2025
Eric Horvitz,

Shrey Jain
Episode 7: The road ahead
May 1, 2025
Jonathan M. Carlson,

Will Guyman,

Matthew Lungren

, et. al.
Microsoft Research India - The evolution
March 1, 2025
Venkat Padmanabhan,

P. Anandan,

Rick Rashid

, et. al.
Microsoft Research India - The lab culture
March 1, 2025
P. Anandan,

Indrani Medhi Thies,

B. Ashok

, et. al.

Your Privacy Choices